These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6873027)

  • 1. An overview of current efforts in short-term carcinogen testing.
    Milman HA; Hurley PM; Auletta A
    Environ Health Perspect; 1983 Apr; 50():355-7. PubMed ID: 6873027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Nesnow S; Argus M; Bergman H; Chu K; Frith C; Helmes T; McGaughy R; Ray V; Slaga TJ; Tennant R
    Mutat Res; 1987; 185(1-2):1-195. PubMed ID: 3540654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hazard identification: efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens.
    Waters MD; Stack HF; Jackson MA; Bridges BA
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):61-72. PubMed ID: 8143649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity.
    Dearfield KL; Auletta AE; Cimino MC; Moore MM
    Mutat Res; 1991 Nov; 258(3):259-83. PubMed ID: 1719404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GENE-TOX program: genetic activity evaluation.
    Waters MD; Auletta A
    J Chem Inf Comput Sci; 1981 Feb; 21(1):35-8. PubMed ID: 7240352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments and perspective on the EPA workshop on "The relationship between short-term test information and carcinogenicity".
    Kier LD
    Environ Mol Mutagen; 1988; 11(1):147-57. PubMed ID: 2892675
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of the carcinogenicity prediction and battery selection (CPBS) method to the Gene-Tox data base.
    Pet-Edwards J; Chankong V; Rosenkranz HS; Haimes YY
    Mutat Res; 1985 May; 153(3):187-200. PubMed ID: 3990701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of short-term tests and limited bioassays in carcinogenicity testing.
    Pienta RJ; Kushner LM; Russell LS
    Regul Toxicol Pharmacol; 1984 Sep; 4(3):249-60. PubMed ID: 6387819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Heidelberger C; Freeman AE; Pienta RJ; Sivak A; Bertram JS; Casto BC; Dunkel VC; Francis MW; Kakunaga T; Little JB; Schechtman LM
    Mutat Res; 1983 Apr; 114(3):283-385. PubMed ID: 6339891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental status of bioassays in genetic toxicology. A report of Phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Brusick D; Auletta A
    Mutat Res; 1985; 153(1-2):1-10. PubMed ID: 3974625
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and impact of the Gene-Tox-Program, genetic activity profiles, and their computerized data bases.
    Waters MD
    Environ Mol Mutagen; 1994; 23 Suppl 24():67-72. PubMed ID: 8162911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic toxicology of putative nongenotoxic carcinogens.
    Jackson MA; Stack HF; Waters MD
    Mutat Res; 1993 Mar; 296(3):241-77. PubMed ID: 7680106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro testing for carcinogens and mutagens.
    Santella RM
    Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of the Gene-Tox Program.
    Auletta AE; Kier LD; Mitchell AD
    Prog Clin Biol Res; 1990; 340D():273-81. PubMed ID: 2371300
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.